Non-Interventional Observational Study to Evaluate Change of PSA Levels in Patients With Advanced Prostate Cancer Treated With Bicalutamide in Combination With Medical or Surgical Castration.
Phase of Trial: Phase IV
Latest Information Update: 16 Apr 2010
At a glance
- Drugs Bicalutamide (Primary)
- Indications Prostate cancer
- Focus Therapeutic Use
- Sponsors AstraZeneca
- 10 Jun 2017 Biomarkers information updated
- 16 Apr 2010 Actual patient number (340) added as reported by ClinicalTrials.gov.
- 16 Apr 2010 Actual end date (January 2010) added as reported by ClinicalTrials.gov.